University of Alabama at Birmingham- Site Number : 8400003

Birmingham, Alabama 35233

2 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Sickle Cell Disease

Studies at this site

• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease — Recruiting now
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype — Recruiting now